Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

This study is ongoing, but not recruiting participants.

Study NCT00004884 Information provided by National Cancer Institute (NCI)

First Received: March 7, 2000 Last Updated: July 23, 2008 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Pancreatic Cancer

Additional conditions recognized in this trial

Pancreatic Neoplasms

More general conditions related to this trial

Interventions listed in this trial

cisplatin
docetaxel
gemcitabine hydrochloride

Additional drug interventions recognized in this trial

Gemcitabine

More general drug interventions related to this trial

Sponsors listed in this trial